“They work in the brain,” Ania Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale University, tells PEOPLE of these drugs that satiate users.

Ania Jastreboff, M.D., PhD., an obesity medicine physician scientist at Yale University, tells PEOPLE that some patients notice a reduced craving for alcohol when on the medications.

Yale School of Medicine endocrinologist, Dr. Ania Jastreboff and colleagues are studying the impact of the diabetes medication tirzepatide, sold under the brand name Mounjaro.

"Imagine a future where we're treating obesity and, in effect, treating these other obesity-related diseases" like hypertension, high cholesterol and type 2 diabetes, Dr. Ania Jastreboff, director ...

Oprah Winfrey's comments about weight-loss drugs and "thin people" have stirred intense reactions across social media platforms.

Among 127 people with both obesity and type 2 diabetes, the mean percent change in body weight from baseline to week 52 ranged from -8.4% to -12.3% in the maridebart cafraglutide groups versus -1. ...

The effects that semaglutide has on insulin production and feeling full all start in the brain, Dr. Ania Jastreboff, associate professor at Yale School of Medicine and obesity medicine physician ...

News 8 sat down with Dr. Ania Jastreboff, a Yale associate professor, endocrinologist and obesity medicine physician, to discuss these weight loss drugs. She leads the Yale Obesity Research Center ...

On the Jan. 14 episode of The Oprah Podcast, the former talk show host had a conversation with Yale University obesity medicine physician scientist Dr. Ania Jastreboff and clinical psychologist Dr ...

“One of the things that I realized the very first time I took a GLP-1 [Glucagon-like peptide-1] was that all these years I thought that thin people had more willpower,” Winfrey told Dr. Ania ...